common.study.topics.clinical

CMF Bone Stimulation Treatment of Ankle Fractures

common.study.values.description

CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

The OL1000 is intended to be used as a non-invasive adjunctive treatment for adult males or females that have sustained a closed, unstable ankle fracture that requires surgical treatment for stabilization. The initiation of the adjunctive treatment is to begin within 11 days of surgical stabilization.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Device - Active Combined Magnetic Field OL1000 Bone Growth Stimulator

Active CMF OL1000 Device

Device - Sham Combined Magnetic Field OL1000 Bone Growth Stimulator

Sham CMF OL1000

participant.views.study.view.additional

participant.views.study.view.scientific-title

Prospective, Randomized, Double-Blinded, Controlled Multi-Center Clinical Trial Evaluating the Use of Non-Invasive CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

common.study.values.clinical-trial-id

NCT02688855

participant.views.study.view.id

mepLye